Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks

Chronic hepatitis C patients often fail to respond to interferon-based therapies. This phase III study aimed at confirming the efficacy and safety of glycyrrhizin in interferon + ribavirin-based therapy non-responders. A randomised, double-blind, placebo-controlled, comparison of glycyrrhizin, admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Manns, M P, Wedemeyer, H, Singer, A, Khomutjanskaja, N, Dienes, H P, Roskams, T, Goldin, R, Hehnke, U, Inoue, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584517/
https://www.ncbi.nlm.nih.gov/pubmed/22762137
http://dx.doi.org/10.1111/j.1365-2893.2011.01579.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584517/
https://www.ncbi.nlm.nih.gov/pubmed/22762137
http://dx.doi.org/10.1111/j.1365-2893.2011.01579.x

Ejemplares similares